RAD51 and non-small cell lung carcinoma: Gachehciladze et al. found that immunohistochemical loss of nuclear RAD51 staining is an independent positive prognostic factor in resected non-small cell lung cancer after neoadjuvant chemo- or radiotherapy [19].